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Trypanosoma cruzi. a protozoan parasite, causes American trypanosomiasis or 
Chagas' disease. The infective stage of this parasite resides in the hindgut of the 
reduviid bug (family Reduviidae), which is both host and vector, and is transmitted to 
the mammalian host through fecal material released during a blood meal. Chagas' 
disease, an acute to chronic infection resulting in fever, malaise, and heart and liver 
enlargement, is becoming a concern in the United States due to the large increase in 
Latin American immigrants, and the lack of safe and effective therapeutic treatment 
and vaccination. Another growing concern in the United States involves 
environmental toxicants and their ability to act as immunosuppressants. Lead is of 
particular interest because it is widespread in places such as soil, food, water, batteries, 
paints, and plastics. Studies have shown lead exposure during bacterial and viral 
infection causes decreases in antibody production, T cell recognition, and macrophage 
activity—all of which result in decreased host resistance to infection. The present 
study was conducted to determine the immunosuppressive effects of lead acetate in 
C57B1/6 mice challenged with the Brazil strain of T\ cruzi. Mice were treated with 
Vlll 
lead acetate concentrations ranging from 0 to 1000 p.p.m. in their drinking water for 
three weeks prior to infection. During the fourth week of the experiment, mice were 
injected with lxlO4 blood-form trypomastigotes (BFTs) of T\ cruzi and lead treatment 
was continued. Food and water consumption was measured to monitor feeding 
patterns and lead exposure during infection. Parasitemias were performed at fourteen 
days post infection and continued at 3 and 4 day intervals throughout the study. 
Parasite-specific antibody production was determined by an indirect enzyme-linked 
immunosorbent assay (ELISA) using serum samples collected during high parasite 
counts. Average daily food consumption showed no statistical differences between 
lead-treatment groups of mice per replicate experiment. Average daily water 
consumption and mean weight gain showed no statistical differences among groups in 
replicates II and III; however, in replicate I significant differences were observed in 
both variables between mice receiving 100 and 1000 p.p.m. lead acetate 
concentrations. The highest mean peak parasitemias were observed in mice receiving 
100 and 1000 p.p.m. lead acetate, though high lead acetate concentrations did not 
appear to suppress T\ cruzi-specific antibody production. Although low mortality was 
observed in lead-treated mice, the results of this study suggest that lead exposure does 
enhance the susceptibility of mice to infection with T\ cruzi, resulting in high 
parasitemias. 
IX 
INTRODUCTION 
Toxicology 
Toxicology has been defined by Newcombe (1992) as "the science dealing with 
chemicals that cause disease." For a chemical to be classified as a toxicant, it must 
enter the host organism through one of several exposure routes: dermal; oral; 
inhalational; or intravenous. Exposure time of toxicants may vary from acute (four-six 
hours) to chronic (three months to two years). There are many ways to classify a 
toxic substance including primary target organ, use of substance, exposure time, 
exposure route, physical state of substance, chemical qualities of substance, and 
biochemical processes used to eliminate the substance. Pesticides, radiation, animal 
toxins, and heavy metals are the toxicants which have been most studied to date 
(Houston, W.E. 1994, pers. comm.). Heavy metals have become a particular concern 
because many are found naturally. The effects of metals depend on several factors 
including concentration, duration of exposure, species and sex of the host, and route of 
exposure. 
Immune Response Mechanisms 
The immune system is complex and involves a variety of different cell types 
which interact with foreign substances in a host organism. The defense mechanisms 
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used by the host include innate immunity and acquired immunity. The innate immune 
response involves the general defense mechanisms of a host including anatomic, 
physiologic, endocytic and phagocytic, and inflammatory (Kuby, 1994). The primary 
characteristics of acquired immunity are specificity, diversity, self/nonself recognition, 
and immunological memory (Kuby, 1994). The host is able to mount a heightened 
and more rapid response to a repeated exposure to antigen due to immunological 
memory. 
Cellular and humoral immunity are two mechanisms involved in acquired 
immunity. The cellular response consists of those reactions that operate through the 
specificity and direct activity of T lymphocytes, and manifest as either cell-mediated, 
delayed-type hypersensitivity (DTH), tumor and allograft rejection, or allogeneic 
disease (Kuby, 1994). Cell-mediated immunity involves the activity of CD8+ T 
cytotoxic cells and occurs when the T cells respond to specific antigens. Delayed-type 
hypersensitivity, a type IV hypersensitive response mediated by T cells, is a response 
that occurs approximately two or three days after the T cell interacts with an antigen 
and involves the release of particular cytokines, such as, interleukins 2 and 3, tumor 
necrosis factor (3, and interferon y (Kuby, 1994). The DTH response is particularly 
important in defending the host against bacterial and parasitic infections. 
Humoral immunity functions by producing antibodies which are circulated 
through the serum. There are five classes of immunoglobulin in humans, designated 
IgM, IgG, IgA, IgE, IgD. IgG and IgM classes of immunoglobulins are extremely 
useful in defending the host against extracellular bacteria and exotoxin-producing 
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bacteria due to their agglutinating properties and their ability to fix complement 
(Kuby, 1994). 
Lymphocytes are important in both acquired and innate immunity. One type of 
lymphocyte, the T cell, arises from hematopoietic stem cells in the bone marrow and 
completes its maturation in the thymus gland (Kuby, 1994). T cells divide and 
become distinct as either helper, cytotoxic, or memory cells. The other type of 
lymphocyte, the B cell, arises from stem cells in the bone marrow and remains in the 
marrow until maturation. B cells produce antibodies and influence T cells by acting as 
antigen-presenting cells. CD4+ T helper cells (class II major histocompatibility 
complex (MHC)-restricted) recognize antigen-class II MHC complex on an antigen-
presenting cell. T cell receptor (TcR) recognition involves the formation of a tri-
molecular complex (MHC + antigen + TcR) (Kuby, 1994). Once the complex is 
bound the T helper cell is activated to secrete a variety of cytokines which stimulates 
B lymphocytes to undergo clonal expansion. In this process, B cells divide repeatedly 
and differentiate into plasma cells (antibody secreting) and memory cells (expressing 
membrane-bound antibody) (Kuby, 1994). IgG and IgM class immunoglobulins 
participate in the enhancement of phagocytosis, neutralization of toxicity, and 
complement-mediated lysis (Caren, 1981; Kuby, 1994). CD8+ cytotoxic T cells (class 
I MHC-restricted) destroy tumor cells and foreign cells upon contact. Memory T cells 
are responsible for the enhanced recognition response to a specific foreign substance. 
Most antigens require the participation of both T helper and B cells to stimulate an 
antibody response. 
Macrophages play a major role in the immune response as antigen processing 
and antigen presenting cells. Macrophages are derived from monocytes, and both cell 
types are actively phagocytic. Macrophages and monocytes process and present the 
antigen in association with class 13 MHC molecules to CD4+ Th cells, secrete 
cytokines, and respond in antibody-dependent cell-mediated cytotoxicity (Kuby, 1994). 
Immunotoxicology 
The field of immunotoxicology combines knowledge from immunology and 
toxicology to determine the effects of toxicants on the immune system. As a 
discipline, immunotoxicology involves the study of opposing effects of occupational, 
inadvertent, or therapeutic exposure to drugs and environmental chemicals or 
biological products on the immune system of living organisms (Exon, 1990). The 
field of immunotoxicology was initiated in the 1970's when researchers began 
investigating the immunotoxic potential of two environmental chemicals, 
polychlorinated biphenyls (PBCs) and lead (Loblay and Neill, 1992). Through the 
1970's and early 1980's, the number of studies increased and the international 
awareness of immunotoxicology grew (Exon, 1990). 
Immunotoxicants can be xenobiotic (pharmaceuticals, cosmetics, food 
additives, agricultural chemicals, environmental pollutants, and natural toxins) or 
biological products (enzymes, hormones, vaccines, allergen extracts, blood products, 
monoclonal antibodies, interferons, interleukins, growth factors, and other cytokines) 
(Loblay and Neill, 1992). There are three modes of action by which xenobiotics may 
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induce immunosuppression: hormonal effects caused by xenobiotic-induced changes in 
normally secreted hormone levels; chemically-induced functional defects of cells in the 
immune response; and chemically induced depletion of responding cells (Faith et al., 
1980). Chemical induction, which results in a decreased number of responding cells 
correlates with defects in cellular activation or initiation of suppressor cells (Faith et 
al, 1980). When the responding cells are affected, lymphocytes may die, blockage of 
lymphocyte maturation may occur, and there may be interference with lymphocyte 
activity (Faith et al, 1980). 
The immune system may respond to an immunotoxicant by suppression or 
enhancement of reactions directed against the chemical or one of its metabolites. 
Immunosuppression may result in increased susceptibility of the host to viral, bacterial, 
fungal pathogens, or cancer (Vos, 1977). Immunosuppressive compounds are typically 
drugs, alkylating agents, thiopurines, folic acid antagonists, pyrimidine nucleoside 
analogues, some antibiotics, industrial chemicals, pesticides, and heavy metals (Vos, 
1977; Koller, 1979). An immunosuppressive substance may act upon rapidly dividing 
cells such as lymphocytes, hemopoietic, and reproductive cells (Vos, 1977). The 
effects on the immune system are not selective and can impact the immune system 
directly or indirectly. 
One successful approach to determining if an environmental contaminant could 
affect the immune system, thus enhancing susceptibility to infection, is to inject the 
host with an LD50 dose of a bacterial or a viral pathogen during exposure to a toxicant 
(Koller, 1979). An LD50 dose is lethal to 50 % of the individuals given that dose. In 
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1971, Hemphill et al. studied the ability of lead to suppress host resistance to 
Salmonella typhimurium. hypothesizing that exposure to low concentrations of lead 
would cause mice to have decreased resistance to bacterial infection. Swiss-Webster 
mice were exposed to subclinical doses (either 100 (ag or 200 jig) of lead nitrate for 
thirty days (Hemphill et al., 1971). There were no overt clinical signs of toxicity 
observed during the observation period, despite indications of enhanced susceptibility 
to the bacteria. A Tenfold increase in mortality with an LD50 (10"4 7) of SL 
typhimurium was observed in lead-treated mice relative to controls. Hemphill et al. 
(1971) concluded there was a negative impact of lead exposure on the immune system, 
causing decreased resistance of the host against SL typhimurium and resulting in high 
mortality. It is known that lead has the ability to bind to proteins in vitro and possibly 
in vivo. Hemphill et al. (1971) suggested the ability of lead to bind to various 
complement proteins, involved in antigen-antibody interaction, may interfere with the 
functional activity of the alternative and the classical complement pathways, thus 
decreasing the resistance of the host to Jv typhimurium. 
Prior to 1977, most of the studies involving lead focused on increased 
susceptibility to infectious gram-negative bacteria containing endotoxins (Vos, 1977). 
Seyle et al. (1966) studied the effects of lead on rats exposed to a bacterial endotoxin. 
A greater sensitizing effect was observed when lead and Escherichia coli endotoxin 
were given simultaneously (Seyle et al., 1966). In this case, susceptibility to 
endotoxin was shown to increase approximately 100,000 times; when rats were treated 
with 100 fag of K coli endotoxin, the death rate and histopathology was the same as 
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when the rats were exposed to 1 ng of K coli and 5 mg/100 g body weight of lead (a 
well tolerated dose). 
The effects of methylmercury, tetraethyl lead, and sodium arsenite on the 
humoral immune response of Swiss cross male mice also have been examined (Blakley 
et al., 1980). This particular experiment lasted for three weeks, with groups of mice 
receiving concentrations of between 0.5 and 10.0 p.p.m. of methylmercuiy, tetraethyl 
lead, or sodium arsenite in their drinking water. The mice in this study did not show 
signs of toxicity to either methylmercury, tetraethyl lead, or sodium arsenite; however, 
maximum immunosuppression of antibody-producing cells and antibody production 
was found in all metal concentrations of 0.5 and 1.0 p.p.m. and somewhat less 
immunosuppression with 2.0 p.p.m. A dose-related effect on tissue-metal 
concentrations was observed at all metal concentrations when the kidney and the liver 
were analyzed (Blakley et al., 1980). High lead concentration exposure resulted in 
high tissue-lead concentration. The authors of the study suggested that the mechanism 
of suppression may have involved impairment of macrophage function or depression of 
particular lymphocyte subpopulations (Blakley et al., 1980). 
Koller et al. (1979) conducted a study to determine if lymphocytes obtained 
from CBA mice treated with lead or cadmium would have an altered response to 
mitogen stimulation. Twenty-five mice (group 1) were given 13, 130, or 1300 p.p.m. 
lead acetate, and twenty-five mice (group 2) received 3, 30, or 300 p.p.m. cadmium 
chloride in their drinking water for ten weeks. Selected animals in each group were 
injected with Mycobacterium bovis (BCG). Neither lead nor cadmium had an 
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observable effect on T lymphocyte proliferation induced by exposure to the mitogen 
concanavalin A (Con A). Lead treatment did result in depression of the proliferative 
response of lymphocytes to the mitogens lipopolysaccharide (LPS) and purified protein 
derivative (PPD), while cadmium actually stimulated blastogenesis in response to these 
mitogens (Koller et al., 1979). 
Faith et al. (1979) investigated chronic, low concentration lead exposure on 
Sprague Dawley rats. Newborn female rats were given 25 and 50 p.p.m. lead acetate 
in their drinking water for seven weeks. The rats were mated with untreated males 
and continued on the lead-treatment through gestation and lactation. Male and female 
offspring were maintained on the same regimen as the mother, and between the ages 
of 35 and 45 days, were studied for immunological effects. Second generation rats 
showed no differences in growth rate and no clinical signs of toxicity were observed. 
Both male and female offspring had significantly lowered thymic weights at birth in 
each treatment condition relative to controls. Researchers found lead treatment 
depressed the ability of the lymphocytes to respond to mitogen stimulation with 
phytohaemagglutin-p (PHA) or Con A and delayed-type hypersensitivity to PPD 
challenge. The decrease in thymic cell proliferation in response to Con A was not 
significantly different among lead-treatment groups. T lymphocyte proliferation in 
response to PHA or Con A demonstrated a statistically significant decrease in both 
lead-treatment groups relative to controls. These results suggest that long-term 
exposure to lead may lead to immunosuppression of cell-mediated and humoral 
immune function (Faith et al., 1979). 
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Koller (1973) analyzed the effects of lead, cadmium, and mercury on the 
humoral antibody response in rabbits exposed to a viral pathogen. New Zealand 
White male rabbits were exposed to 2500 p.p.m. lead acetate, 300 p.p.m. cadmium 
chloride, or 10 p.p.m. mercuric chloride for 70 days. No clinical signs of toxicity 
were observed. The animals were challenged with pseudorabies virus (Herpesviridae 
family) on day 71, with a second dose day 78, and a third dose on day 85. Serum 
samples were prepared on the same days for use in ELISA assays to determine 
antibody production. The lead-treated rabbits showed an approximate tenfold decrease 
in antibody production. Mean serum-antibody titers were significantly decreased in all 
treatment metal groups relative to controls. Mercury-treated rabbits showed the least 
decrease in antibody titers compared to other metal treatment groups. There also was 
a significant decrease in the packed cell volume and body weight gain of the lead-
treated groups, though no such decreases were observed in cadmium- or mercury-
treated rabbits (Koller, 1973). 
Koller and Kovacic (1974) studied Swiss-Webster mice exposed to 13.75, 
137.5, or 1375 p.p.m. lead acetate concentrations in their drinking water for 56 days. 
Mice were inoculated with sheep red blood cells (SRBC) and their antibody production 
was measured. The results showed a decrease in antibody production and numbers of 
B lymphocytes relative to controls (Koller and Kovacic, 1974). IgG antibody response 
was low, suggesting that memory cells were affected by lead acetate exposure. The 
longer the animals were exposed to lead, the greater the decrease of both IgM and IgG 
antibody production. Koller and Kovacic (1974) suggested lead acetate decreased the 
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number of antibody-producing cells, leading to a decrease in the level of circulating 
antibodies, and that the reduction in antibody production is responsible for the 
increased risk of bacterial or viral disease in animals with chronic exposure to lead. 
Koller and Brauner (1977) also studied the effects of lead and cadmium 
exposure on B lymphocytes in CBA/J mice. Twenty-five CBA/J mice exposed to 13, 
130, or 1300 p.p.m. lead acetate or 3, 30, or 300 p.p.m. cadmium chloride in their 
drinking water for 70 days. No toxic signs were observed. The number of 
erythrocyte-antibody-complement (EAC) rosettes were significantly lower in the mice 
treated with 130 or 1300 p.p.m. lead or 30 p.p.m. cadmium as compared to the control 
group. Exposure to lead and cadmium was associated with decreased formation of 
rosettes, thus accounting for the decrease in antibody response occurring during 
primary immunity (Koller and Brauner, 1977). Koller and Brauner (1977) suggested 
that, in this experiment, because the lymphocyte viability and percentage T and B cells 
were common between treatment groups, the complement receptor site on the surface 
of the B cell was altered by lead and cadmium exposure. A direct inhibition of B 
cells due to lead and cadmium exposure represents an obvious danger to the health of 
a host, as B cells produce antibodies (Koller and Brauner, 1977). 
BDF, female mice were used to study the effects of lead acetate on 
macrophage activity (Blakley and Archer, 1981). Concentrations of lead acetate 
ranged from 50 to 1000 p.p.m. and were administered in drinking water for three 
weeks. Suppression of macrophage activity by lead exposure was observed when 
macrophage-dependent antigens, SRBC, or dinitrophenyl-Ficoll was used; however, 
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when the macrophage-independent antigen R coli LPS was used, no such suppression 
was seen (Blakley and Archer, 1981). There were no signs of lead toxicity expressed 
by the mice. Results of this study indicated that lead exposure suppressed the immune 
response by compromising early macrophage function. The specific effect has yet to 
be identified but may involve recognition of the antigen, antigen processing, or 
amplification of the immune response (Blakley and Archer, 1981). 
Phagocytosis and oxidative metabolism of cadmium and lead by peritoneal 
macrophages was studied by Hilbertz et al. (1986). Oxidative metabolism induced by 
phorbol myristate acetate (PMA) solution was enhanced by exposure to both metals; 
however, zymosan-induced oxidative metabolism was decreased significantly by 
cadmium exposure (and to a lesser extent by lead exposure) within the first hour of 
exposure (Hilbertz et al., 1986). After 20 hours, lead exposure suppressed oxidative 
metabolism induced by zymosan and PMA along with the phagocytosis of latex-
particles in a concentration-dependent manner. Lead exposure reduced cell viability 
only slightly (Hilbertz et al., 1986). These results suggest that the enhancement of 
PMA-induced oxidative metabolism in the first hour of treatment with lead or 
cadmium results in increased release of toxic oxygen metabolites into the surrounding 
environment of the cell, thus impairing the defense mechanisms of macrophages 
(Hilbertz et al., 1986). 
Because lead has been found to be an immunosuppressant, Sin and Woo (1992) 
wanted to determine whether lead exerted a detrimental effect on phagocytic functions 
under acute inflammatory conditions. Female Swiss albino mice were given 2000 
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p.p.m. lead nitrate in their drinking water for three months. Two months after initial 
lead exposure the mice were vaccinated with formalin-killed parasites, Trypanosoma 
e van si. One month after immunization the mice were infected with live T\ evansi 
parasites. The results suggested lead-treated mice were not immunologically protected 
from T\ evansi infection after immunization. The total number of phagocytes in the 
lead-treated mice was significantly reduced compared to controls, suggesting a 
reduction in the total number of exudate leukocytes. This study also demonstrated 
lead-treatment to be detrimental to the nonspecific immune response by decreasing the 
chemotactic response of neutrophilic polymorphonuclear leukocytes (PMN) to 
inflammation. Lead may affect mononuclear phagocytes as well, causing the host to 
be more susceptible to infection (Sin and Woo, 1992). 
Lawrence (1981) discussed the ability of heavy metals to reduce humoral 
immunity, cell-mediated immunity, and lymphocyte division. However, Lawrence 
(1981) describes lead and nickel demonstrating immunopotentiating effects by 
enhancing the maturation of B cells into plaque-forming cells (PFC). This effect was 
greater than the effect upon the development of mixed lymphocyte cultures (MLC) 
(Lawrence, 1981). Lead exposure was shown to enhance the MLC response of CBA/J 
spleen cells to C57B1/6 stimulators, thus the ability of lead exposure to enhance the 
PFC response may be caused by the enhanced production of T helper cells (Lawrence, 
1981). Lawrence demonstrated that T-dependent and T-independent responses were 
equally enhanced by lead exposure. Immunopotentiating effects of lead and nickel 
may be due to modulation of B cell, T cell, or macrophage functions (Lawrence, 
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1981). 
Previously heavy metals have been shown to decrease antibody production, 
TcR recognition to antigen, and macrophage activity; however only recently metal 
toxicity and autoimmune response has been examined. Kowolenko et al. (1992) 
hypothesized that heavy metal toxicity may be due in part to autoimmunity. Heavy 
metals have been shown to directly modulate lymphocyte function leading to enhanced 
B and T cell activity which may result in autoimmunity (Kowolenko et al., 1992). 
One particular heavy metal, lead, has been shown to affect the function of CD4+ T cell 
subset which regulates all immune responses (McCabe and Lawrence, 1990). Lead 
was also found to inhibit T helper 1 cell function but to enhance T helper 2 cell 
function. These two subpopulations of cells (Th 1 and Th 2) function to regulate cell-
mediated and humoral immunity (Kowolenko et al., 1992). Heavy metals are also 
believed to be inducers of allergic hypersensitivity (Kowolenko et al., 1992). Type I, 
II, and III hypersensitivity responses involve the production of antibody, while type IV 
involves a cell-mediated response. All hypersensitivity responses are activated when 
lymphocytes are sensitized by internal or external factors (Kowolenko et al., 1992). 
Toxicants can cause a direct effect on the immune system by changing the lymphocyte 
subset ratio, changing the morphology of the immune tissue, reducing the total number 
of immune cells, or by changing the function of the immune system with or without 
the above alterations (Luster et al., 1984). Toxic substances may cause tissue damage 
resulting in the release of sequestered antigens or an increased number of tissue 
antigens, thereby stimulating the immune system and causing autoimmunity 
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(Kowolenko et al, 1992). In addition, toxicants depress immune cells, causing an 
increased incidence of infections and possibly an increase in autoimmune responses 
(Kowolenko et al., 1992). 
Immunoassays 
Although a number of immunoassays have been developed during the last ten 
years, only a few have been adapted to evaluate the effects of toxicants on the immune 
system. Three main assays have been used to evaluate the humoral immune response: 
the antibody-forming cell response to T-dependent SRBC antigens; the proliferative 
response to B cell mitogen LPS; and the quantification of the number of B cells in the 
spleen (White, 1992). Measurement of the antibody-forming cell response has proven 
very useful, as it is a good indicator of general immunocompetence. Methods used to 
determine antibody-forming cells include enzyme-linked immunospot, filter immuno-
plaque assay, and to measure antibody production enzyme-linked immunosorbent assay 
(ELISA) is used. The antibody-forming cell assay is sufficient in recognizing 
compounds which modulate the immune response because it is holistic in nature 
(White, 1992). There are also a few assays which have been used to determine the 
effects of toxicants on cell-mediated immunity: the mixed leukocyte response (MLR); 
the spleen lymphocyte response to T lymphocyte mitogen Con A; the cytotoxic T 
lymphocyte assay (CTL); and the delayed hypersensitivity response (DHR) to keyhole 
limpet haemocyanin (KLH) (White, 1992). The National Toxicology Program (NTP) 
also has selected assays to study natural killer (NK) cell functions and macrophage 
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activity (White, 1992). 
Lead 
Lead, an inorganic heavy metal, is a naturally occurring element which has 
been redistributed by humans. A large number of people and animals are exposed to 
lead on a daily basis, as lead is found in air, soil, paint, plastic, water, food, products 
of burnt coal, and batteries. Humans and animals are exposed to lead via inhalation 
and ingestion (Faith et al, 1979). Lead poisoning has been documented when 
contaminated foods and beverages were consumed, when plumbing fixtures made of 
lead have been used in homes, and when cooking utensils containing lead were used to 
prepare food (Faith et al, 1979). Because it causes extensive CNS damage (Goyer, 
1991), lead poisoning is a major threat to the health of young children and infants. A 
variety of studies also have shown that lead suppresses the immune system. 
Depression of the activity of the immune system by lead exposure occurs at low 
subclinical doses and is therefore considered to be deleterious to the health of animals 
(Faith et al, 1979). 
Koller (1980) suggested that studies should be conducted to determine how 
contaminants affect the activity of B cells, T cells, macrophages, and the interaction of 
these cells in both in vitro and in vivo conditions. Lead exposure is known to 
suppress phagocytic function, thus reducing the immune response due to impairment of 
antigen processing and presentation by macrophage (Exon, 1990). Lead exposure 
has also been shown to affect the cell-mediated response. Faith et al (1979) 
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demonstrated impairment of the delayed-type hypersensitivity response in Sprague 
Dawley rats exposed to lead acetate. In an in vitro study of T-lymphocyte activity, 
CBA/J and C57B1/6 mice infected with Listeria monocytogenes and treated with high 
concentrations of lead acetate showed a slight reduction in T cell activity (Lawrence, 
1981). 
Chagas' disease 
In 1907 Carlos Chagas located an area of Brazil, Minas Geraes, where thatched 
roof houses were infested with blood sucking (haematophagus) bugs, Conorhinus 
megistus. The bugs were examined and flagellated protozoa were found in their 
hindguts. Flagellates could be found in the bloodstream 20-30 days after an individual 
was bitten by the reduviid bug. The bugs were examined at the Institute Oswaldo 
Cruz, thus the parasites were termed Trypanosoma cruzi (Minchin, 1910). 
The causative agent of Chagas' disease is the flagellated protozoan, 
Trypanosoma cruzi. which has a single nucleus and undergoes three life cycle stages: 
(1) the intracellular amastigote stage, which is round and lacks a flagellum replicates 
in the mammalian host; (2) the epimastigote stage, which possesses a juxtanuclear 
kinetoplast and a flagellum replicates in the vector; and (3) the trypomastigote stage, 
which possesses a flagellum and has a post-nuclear kinetoplast does not replicate 
(Wendel and Gonzaga, 1993). Amastigotes are found in vertebrate macrophages, 
muscle fibers, and within cells of the central nervous system (CNS). Epimastigotes 
are seldom detected in the vertebrate bloodstream; however, this form is common in 
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the foregut of the reduviid bug. Trypomastigotes are located in the vertebrate 
bloodstream, lymph and cerebrospinal fluid, and in the invertebrate duodenum and 
hindgut (Wendel and Gonzaga, 1993). Trypomastigotes are approximately 20 jam 
long, may be short and thick or long and slender, and form a characteristic C or U 
shape in bloodsmears (Markell et al., 1986). 
Transmission 
The trypomastigote is the infective stage of the parasite for humans. T. cruzi 
parasites are introduced via fecal material into the bitten area when a reduviid bug 
takes a blood meal. Infection occurs when infective trypomastigotes are rubbed into 
the wound or eye, or cross the mucosa. Lymph fluid transports the parasites to the 
lymph nodes. After the trypomastigote enters the bloodstream it invades macrophages 
or other nucleated cells where it transforms into the amastigote stage and divides by 
binary fission. The amastigote avoids degradation by escaping the phagosome and 
entering the cytosol of the macrophage prior to lysosomal fusion. Amastigotes 
transform back into trypomastigotes, which are released when the cell ruptures and are 
free to invade other cells or enter the circulatory system. The trypomastigote can 
independently penetrate nucleated cells or it may gain access by phagocytosis. The 
organs most susceptible to infection are spleen, liver, lymph nodes, and muscles 
(skeletal and cardiac). The infection also effects the nervous system, reproductive 
system, intestine, Kupffer cells, reticuloendothelial cells, and bone marrow (reviewed 
in Bogitsh and Cheng, 1990). 
18 
T cruzi has several natural reservoirs including skunks, marmots, sloths, bats, 
foxes, jaguars, ferrets, rabbits, mice, hamsters, marmosets, armadillos, raccoons, 
opossums, monkeys, and squirrels (Wendel and Gonzaga, 1993). It has been shown 
that birds and reptiles are resistant to T\ cruzi infection (Wendel and Gonzaga, 1993). 
Chagas' disease via blood transfusions is relatively frequent (200 reported cases, many 
go unreported) in Latin America. Infected individuals tend to live in low 
socioeconomic areas where blood screening is not available. Even when screening 
tests are performed on blood donor samples, T. cruzi has a phenomenal viability. 
Whole blood infected with T\ cruzi can survive refrigeration for 18 days and withstand 
freezing for 24 hours, indicating a high risk of transmission via blood transfusions. 
All blood products, unless sterilized, may be infectious. The frequency of 
transmission through blood transfusions depends on parasite strain, parasitemia levels 
of donor blood, recipient's immune system, and quantity of blood transfused (Wendel 
and Gonzaga, 1993). Tissues used for organ transplantation can also transmit T cruzi 
infection (Wendel and Gonzaga, 1993). 
Reports indicate congenital transmission is possible yet uncommon. Breast 
feeding has also been shown to be a possible mode of transmission (Wendel and 
Gonzaga, 1993). 
Disease symptoms and stages 
Chagas' disease is most common and most severe in children under five. 
Symptoms occur predominantly in the central nervous system (CNS), and children may 
19 
develop meningoencephalitis and die within days. Infants experience fever, 
lymphadenitis, hepatosplenomegaly, and anasarca (Markell et al., 1986). 
Older children and adults typically have a milder, subacute, or chronic form of 
the disease with no CNS complications (Markell et al, 1986). The acute stage ends in 
a few weeks either in death (approximately 10% frequency) (Miles, 1983), full 
recovery, or transition to the chronic stage. 
Following infection, the parasites enter the subcutaneous tissue macrophages 
where localized swelling occurs (chagoma). Facial and ocular edema is commonly 
unilateral (Wendel and Gonzaga, 1993). The lesion reaches full size within several 
days and slowly decreases size in two or three months (Markell et al., 1986). 
Symptoms of infection appear four to fourteen days post inoculation. Parasites can be 
microscopically detected on day 10 of infection and persist during the acute phase. 
The symptoms during the acute stage of infection include fever, malaise, and 
headaches. Hepatosplenomegaly and myocardial damage may occur; however, cardiac 
involvement and gastrointestinal symptoms may not appear until many years following 
infection (Bogitsh and Cheng, 1990). Other clinical observations include tremors, 
seizures, meningitis, and lymphadenopathy (Wendel and Gonzaga, 1993). Patients 
with symptomatic infections may exhibit signs and symptoms of congestive heart 
failure (mainly in the right ventricle) but this condition is rare in patients under 25 
years of age (Markell et al., 1986). In early chronic stages, the heart may be normal 
in size or slightly larger; however, in late stages approximately 30% of infected 
individuals develop severe cardiomegaly (Miles, 1983). Inflammation, fibrosis, and 
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infiltration by lymphocytes, macrophages, and plasma cells all occur within cardiac 
muscle. 
Iminunoprotection of T. cruzi 
Immunoprotective mechanisms for T\ cruzi infection involve both humoral 
immunity and cell-mediated immunity. Immunoglobulin class IgG is the primary 
antibody produced during the course of infection (Markell et al., 1986). Parasite lysis 
is achieved by: antibody-dependent and complement-mediated mechanisms; natural 
killer (NK) cells; and cytotoxic T lymphocytes (CTL). Activated macrophages, 
neutrophils, and eosinophils also destroy trypomastigotes during cell-mediated 
responses (Markell et al., 1986; Kuhn, 1989). 
Research 
Over the past 15 years, research has been conducted on the immune response 
of lead-treated experimental animals challenged with bacterial and viral infections. 
However, little research has been done on the effects of lead exposure during parasitic 
infection. In the present study, the effect of lead acetate treatment during infection 
with Trypanosoma cruzi was investigated. 
The present study was designed to examine the effects of high lead acetate 
concentrations on the humoral immune response of C57B1/6 female mice when 
challenged with T\ cruzi. Same sexed animals were used in this study to eliminate 
gender variability. C57B1/6 mice are not highly susceptible to the Brazil strain of T 
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cruzi and normally live 46-180 days post infection with parasitemias peaking at 7.5 x 
105 parasites/ml of blood (Grogl and Kuhn, 1985). C57B1/6 mice were chosen for this 
study in order to better demonstrate whether lead acetate showed humoral 
immunosuppressive qualities. The specific questions addressed in this study included: 
1) What is the effect of lead acetate on parasitemia levels?; 2) What is the effect of 
lead acetate on the mortality rate?; 3) How does lead acetate affect parasite-specific 
antibody production?; and 4) Does exposure to lead acetate affect the growth rate of 
mice infected with T. cruzi? 
MATERIALS AND METHODS 
Mice 
Seventy-two C57B1/6 female mice were obtained at 5 weeks of age (Jackson 
Laboratory, Bar Harbor, Maine) and acclimated for two weeks on deionized water and 
Laboratory Rodent Chow (PMI Feeds, St. Louis, Missouri). Mice were then divided 
into three replicate trials containing 24 mice, and each replicate consisted of four 
experimental groups with six mice per group. The four experimental groups were 
given the following lead acetate concentrations in their drinking water for three weeks 
prior to infection: Group 1-0 p.p.m., Group 2-10 p.p.m., Group 3-100 p.p.m., and 
Group 4-1000 p.p.m. After three weeks of lead exposure, mice received an 
intraperitoneal injection of lxlO4 blood-form trypomastigotes (BFTs) of Brazil strain 
Trypanosoma cruzi, which is continuously maintained in the laboratory as a stock 
infection in C3HeB/FeJ mice. Mice in replicates II and III were inoculated with a 
different isolate of the same Brazil strain of T. cruzi as used for mice in replicate I. 
Lead acetate (Sigma Chemical Company, St. Louis, Missouri), 0.002 g, was 
dissolved in 2 L of deionized water to make a 1000 p.p.m. stock solution. The 
remaining concentrations were diluted from the stock. 
H20 and food was provided ad libitum and levels were measured during the 
study. At two week intervals, the weight (g) of each mouse was measured and 
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recorded. 
Preparation of T. cruzi antigen extract 
A PSC3H murine fibroblast cell line infected with T\ cruzi trypomastigotes was 
cultured in RPMI-1640 medium (Sigma) supplemented with 10% newborn calf serum 
(Microbiological Associates, Walkersville, Maryland), 25 mM HEPES (Sigma), and 
penicillin/streptomycin. Culture supernatants containing typomastigote stages were 
collected and filtered through Whatman #1 filter paper. The filtered supernatant was 
then certtrifuged for 30 minutes at 1800 x g. The pellet, which contains parasites, was 
resuspended in 1 ml of Dulbecco's Phosphate Buffered Saline (DPBS), placed in a 1.7 
ml Eppendorf tube (Fisher Scientific, Pittsburgh, Pennsylvania), and centrifuged for 15 
minutes at 2000 x g. The pellets were resuspended two more times, combined and 
resuspended in ice-cold DPBS containing 0.5% Triton X and 2 mM 
phenylmethylsulfonyl fluoride (Sigma) and the suspension was transferred to a 15 ml 
centrifuge tube and incubated for 30 minutes in an ice bath while being vortexed 
periodically. The resulting suspension was spun at 8,000 rpm for 15 minutes to 
remove insoluble material; the supernatant was collected. A Bio-Rad protein 
determination assay was performed on the antigen extract using bovine serum albumin 
as a standard. The antigen extract was diluted to a working concentration of 50 (ig/ml 
in DPBS for use in an indirect enzyme linked immunosorbent assay (ELISA). 
Preparation of murine plasma 
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At two week intervals during the acute stage of infection (14-50 days), 4 of 
tail vein blood was extracted from each of the 72 mice. Blood was transferred to 1.7 
ml Eppendorf tubes, and 96 |il of DPBS were added to each sample. The solution was 
mixed thoroughly then centrifuged at 5,000 rpm for 10 minutes. Plasma samples were 
stored at -4° C until used in indirect ELISA assays. 
Parasitemia 
Parasite counts were conducted at 3 and 4 day intervals starting at day 14 post 
infection. Four |il of tail vein blood was mixed with 96 |al DPBS in Eppendorf tubes, 
constituting a 1/25 dilution. A hemacytometer (Fisher Scientific) was used to count 
the parasites by placing approximately 20 |il of the cell suspension on the slide and 
counting the parasites seen in the four large corner squares. The number of cells/ml of 
blood was calculated using the equation: cells/ml = (avg. number/large square) * 
104/ml * 1/dilution. Parasitemias were conducted until the levels declined to near 
zero. 
Mean peak parasitemias were calculated by determining the peak parasitemia 
for each treatment group for each day analyzed. The three replicate experiments (I, II, 
and III) were combined by calculating the mean peak of all mice receiving each lead 
acetate concentration. 
Indirect ELISA 
Individual wells of 96 well microtiter plates (Falcon) were incubated with 100 
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of a T\ cruzi culture cell antigen extract (50 |j.g/ml in DPBS). Plates were 
incubated at room temperature overnight and then stored at -70° C until use. Thawed 
plates were rinsed three times with fresh DPBS, then blotted dry. Wells were filled 
with blocking solution (2.5% Carnation Instant Nonfat Dry Milk in DPBS) and 
incubated for one hour at 37° C. After incubation, plates were rinsed three times and 
blotted dry. One hundred x^l of 1:25 diluted murine plasma was placed into the first 
well of each row of the microtiter plate and a 2 x serial dilution of the plasma in 
DPBS was performed across the plate. Each sample of murine plasma was tested in 
duplicate rows. Plates were covered and incubated for two hours at 37° C. After 
incubation, plates were washed four times with DPBS. After the fourth wash wells 
were filled with DPBS and incubated for 5 minutes. Once plates were blotted dry, 50 
|al of horseradish peroxidase-conjugated goat anti-mouse immunoglobulin (Sigma) 
diluted 1:1000 in blocking solution was added to each well. Plates were covered and 
incubated for one hour at 37° C. After incubation the plates were washed four times 
with DPBS and blotted dry with paper towels. Fifty microliters of substrate solution 
were added to each well and incubated for 15 minutes at 37° C. Substrate solution 
was prepared by dissolving 30 mg O-phenylenediamine dihydrochloride (OPD; Sigma) 
in 10 ml Tris Citrate Buffer (0.3 M Tris base in 0.5% Triton X-100 pH to 6.0 with 
anhydrous citric acid). Eight |il of 0.025% H202 was added to the solution just prior 
to adding the substrate to the wells. Plates were analyzed on a Model 550 microplate 
reader (Bio-Rad) at an absorbance of 490 nm. Antibody titers were determined 
according to the following equation: titer = highest dilution of the test serum in which 
the absorbance is > .05 and > the mean control absorbance +2 standard deviations. 
Statistical analysis 
Data were analyzed using SYSTAT@ 5.0 (SYSTAT, Inc., 1992). Analysis of 
variance (ANOVA) was used to test for differences in parasitemia counts among lead-
treated groups within individual replicate experiments. To determine which treatment 
groups differed significantly, a pairwise comparison using Tukey's HSD Multiple 
Comparison Test was employed (SYSTAT Inc., 1992). 
To evaluate significant correlation between parasitemia and antibody production 
a Spearman correlation coefficient was used (Wilkinson, 1992). 
To examine potential changes in food and water consumption over time, a 
linear regression analysis of slopes was conducted. Slopes of zero suggest each lead-
treatment group per cage maintained the same diet patterns throughout the study. An 
analysis of covariance (ANCOVA) was used to test for significance among treatment 
groups' diet patterns in each replicate experiment. The assumption of homogeneity of 
slopes was by Multivariate General Linear Hypothesis (MGLH) and when satisfied 
ANCOVA, was employed to test for significance among lead-treated groups. To 
determine which treatment groups differed significantly a pairwise comparison using 
Tukey's HSD Multiple Comparison Test was employed (SYSTAT Inc., 1992). 
Testing for significant changes in mouse weight was conducted by using 
ANCOVA. MGLH and Tukey's HSD test were used as described above. 
RESULTS 
Mortality 
Mortality was low during the course of the present study; however, one mouse 
in replicate I receiving 1000 p.p.m. lead acetate concentrations died on day 63 post 
infection. 
Mouse weights 
In all three replicate experiments weight changed significantly over time; I-
(3=0.019, p<0.001, II-p=0.025, p<0.001, and III-|3=0.025, p<0.001 (Figure 1). 
The assumption of homogeneity of slopes was satisfied for all lead-treatment 
groups in replicate I (F3 ,=0.773, p=0.510). Tests of intercept differences among 
treatment groups were significant (F3 ,=3.766, p=0.012). Pairwise comparisons of all 
lead-treatment groups indicated that mice receiving 100 p.p.m. lead acetate weighed 
significantly more than mice receiving 1000 p.p.m. (p=0.009) (Figure la). 
The assumption of homogeneity of slopes was satisfied for all lead-treatment 
groups in replicates II and III (F3,=0.953, p=0.418 and F31=0.354, p=0.787). 
However, ANCOVA analysis for intercept differences in replicates II and III were 
nonsignificant (F31=0.984, p=0.403 and F31=2.371, p=0.076, respectively) (Figures lb 
and lc). 
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Water and food consumption 
Replicate by treatment combinations showed 10 of 12 regressions of average 
daily water consumption over time were nonsignificant. Mice receiving 10 p.p.m. 
(p=0.023) and 1000 p.p.m. (p=0.001) lead acetate concentrations in replicate I showed 
significant decrease in water consumption over time (Figure 2a). However, when data 
from all treatments are pooled ANCOVA showed there were significant decreases in 
water consumption over time in all three replicates (I-F3 ,=16.750, p<0.001, II-
F3 ,=10.522, p=0.002, ni-F3 ,=8.006, p=0.006) (Figure 2). Nevertheless, average daily 
water consumption among groups in each of the three replicates showed homogeneity 
of slopes (F3,=1.573, p=0.201;F3 ,=9.596, p=0.898 and F3,=4.425, p=0.940, 
respectively). ANCOVA analysis showed significant differences among treatment 
groups in replicate I (F3,=4.672, p=0.004). Mice receiving 100 p.p.m. lead acetate 
concentrations drank significantly more water on average than did mice receiving 10 
or 1000 p.p.m. lead acetate concentrations (p=0.038 and p=0.004, respectively) (Figure 
2a). There were no statistical differences in among treatment groups in replicates II 
and III (F3,,=1.075, p=0.364; F3 ,=0.020, p=0.996) (Figure 2c). 
Replicate by treatment combinations showed 11 of 12 regressions of average 
daily food consumption over time were nonsignificant. One slope from Group 4-1000 
p.p.m. (p=0.022) in replicate I showed significant decrease in food consumption over 
time (Figure. 3 a). However, when data from all treatments are pooled ANCOVA 
showed there were significant decreases in food consumption over time in replicates I 
and III (I-p=0.007 and III-p=0.001) (Figures 3a and 3c). The average daily food 
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consumption in replicates I, II, and III showed homogeneity of slopes among treatment 
groups (F31=0.393, p=0.758), (F3,=0.004, p=1.000) and (F31=0.035, p=0.991); 
however, ANCOVA showed no statistical differences among lead-treatment groups (I-
F3 ,=2.114, p=0.114, II-F3,=0.436, p=0.728, and IH-F3 ,=0.463, p=0.709) (Figure 3). 
Parasitemia 
Overall mean peak parasitemias of each treatment group receiving lead acetate 
are as follows: 0 p.p.m. lead acetate (infected control mice)-6.49 x 106 parasites/ml 
blood; 10 p.p.m. lead acetate-9.61 x 106 parasites/ml blood; 100 p.p.m. lead acetate-
1.31 x 107 parasites/ml blood (twofold higher than infected control mice); and 1000 
p.p.m. lead acetate-3.62 x 107 parasites/ml blood (sixfold higher than infected control 
mice) (Figure 4). 
The highest numbers of circulating blood-form trypomastigotes in all replicates 
were observed in lead-treated mice receiving 100 and 1000 p.p.m. lead acetate 
concentrations (Figure 5). Replicate I showed extremely high parasitemias (7.1 x 
107 parasites/ml of blood) on day 39 of infection in mice receiving 1000 p.p.m. lead 
acetate (Figure 5a). An analysis of variance of parasitemias from day 39 post 
infection was highly significant (F3 ,=30.470, p<0.001); and HSD test showed Group 4-
1000 p.p.m. had significantly higher parasitemias than Groups 1-0 p.p.m. (p<0.001), 2-
10 p.p.m. (p<0.001), or 3-100 p.p.m. (p<0.001) (Figure 5a). 
The highest peak parasitemia in replicate II was 9 x 106 parasites/ml of blood 
observed on day 28 of infection in mice receiving 100 p.p.m. lead acetate (Figure 5b). 
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Mice receiving 1000 p.p.m. lead acetate in replicate II showed two peaks; on day 21 
of infection, mice had an average of 6.0 x 106 parasites/ml of blood, and on day 28 the 
average was 6.5 x 106 parasites/ml of blood (Figure 5b). An analysis of variance 
showed no statistical differences among lead-treatment groups on day 21 (F3>1=1.515, 
p=0.241); however, parasite levels on day 28 differed significantly (F31=5.263, 
p=0.008), as Group 3 showed significantly higher parasitemias than Group 1 (p=0.004) 
(Figure 5b). 
Mice receiving 100 p.p.m. lead acetate in replicate III showed two peaks in 
parasitemias. On day 14 of infection, mice had an average of 1.4 x 107 parasites/ml of 
blood, and on day 21 the average was 1.8 x 107 parasites/ml of blood (Figure 5c). 
Mice receiving 1000 p.p.m. lead acetate concentrations in replicate HI showed their 
peak parasitemia (1.8 x 107 parasites/ml of blood) on day 14 of infection (Figure 5c). 
An analysis of variance of parasitemias on day 14 was highly significant (F3 j=5.849, 
p=0.005); Group 4 had significantly higher parasitemias than Group 1 (p=0.003) 
(Figure 5c). By contrast, on day 21 post infection, (F31=5.797, p=0.005) showed 
Group 1 had significantly higher parasitemias than Group 4 (p=0.004) based on 
ANOVA and HSD tests (Figure 5c). 
Parasite-specific antibody levels 
The parasite-specific antibody production did not show an obvious relationship 
between high lead acetate concentrations (100 and 1000 p.p.m.) and decreased 
antibody production throughout infection in serum samples diluted 1:25 (Figure 6). 
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This dilution was chosen for analysis to demonstrate antibody production at the lowest 
dilution factor. Spearman correlation coefficient testing showed there was not a 
significant correlation between antibody production and parasitemia (p=0.252). 
Parasite-specific antibody production in mice receiving 100 and 1000 p.p.m. lead 
acetate concentrations from replicate I was high on day 32 of infection and low on 
days 18 and 46 of infection (Figure 6a). Infected control mice receiving 0 p.p.m. lead 
acetate showed their peak anti-T\ cruzi antibody production on day 46 post infection 
(Figure 6 a). 
Parasite-specific antibody production in mice receiving 100 p.p.m. lead acetate 
from replicate II was highest on days 21 and 51 of infection and low on day 35 
(Figure 6b). Mice receiving 1000 p.p.m. lead acetate in replicate II showed low 
antibody production on days 21 and 35 of infection and high production on day 51 
(Figure 6b). Infected control mice receiving 0 p.p.m. lead acetate showed their peak 
anti-T\ cruzi antibody production on day 51 post infection (Figure 6b). 
In replicate III the parasite-specific antibody production in mice receiving 100 
and 1000 p.p.m. lead acetate was highest on day 41 of infection and lowest on day 14 
(Figure 6c). Infected control mice treated with 0 p.p.m. lead acetate showed their peak 
anti-T\ cruzi antibody production on day 30 post infection (Figure 6c). Anti-H cruzi 
antibody titers for all replicate experiments are shown in Table 1. 
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Table 1. The titers of anti-T.cruzi antibodies in mice receiving 0, 10, 100, and 1000 
p.p.m. lead acetate concentrations in a) Replicate I, b) Replicate II, and c) Replicate 
III. 
a. 
lead acetate day 18 day 32 day 46 
concentrations 
0 p.p.m. 1:25600 1:800 1:400 
10 p.p.m. 1:1600 1:800 1:6400 
100 p.p.m. 1:6400 1:800 1:3200 
1000 p.p.m. 1:800 1:1600 1:6400 
b. 
lead acetate day 21 day 35 day 51 
concentrations 
0 p.p.m. 1:400 1:50 1:1600 
10 p.p.m. 1:800 1:50 1:800 
100 p.p.m. 1:800 1:1600 1:1600 
1000 p.p.m. 1:100 1:800 1:800 
c. 
lead acetate day 14 day 30 day 41 
concentrations 
0 p.p.m. 1:400 1:6400 1:3200 
10 p.p.m. 1:400 1:51200 1:1600 
100 p.p.m. 1:400 1:1600 1:3200 
1000 p.p.m. 1:800 1:800 1:1600 
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FIGURE 1. Average weights of mice measured over the course of the study before 
and after lead exposure and T. cruzi infection in a) Replicate I, b) Replicate II, and c) 
Replicate III. Results are presented ± 1 SE bar to suggest significance among 
treatment groups. 
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FIGURE 2. Linear regression analysis of average daily water consumption per cage 
measured over the course of the experiment in a) Replicate I, b) Replicate II, and c) 
Replicate III. 
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FIGURE 3. Linear regression analysis of average daily food consumption per cage 
measured over the course of the experiment in a) Replicate I, b) Replicate II, and c) 
Replicate III. 
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FIGURE 4. Mean peak parasitemias ± 1 SE of mice receiving 0, 10, 100, and 1000 
p.p.m. lead acetate concentrations. The peak parasitemia was determined for each 
treatment group for each day analyzed and an average was calculated. All three 
replicate experiments were combined to obtain an overall mean peak parasitemia for 
each lead acetate concentration (n=18 for all groups). 
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FIGURE 5. Mean parasitemias per ml of blood from mice receiving 0, 10, 100, and 
1000 p.p.m. lead acetate concentrations during infection with T. cruzi. Data are 
expressed logarithmically as the average number of parasites per ml of blood in a) 
Replicate I, b) Replicate II, and c) Replicate III. (*) represents days analyzed by 
ANOVA. 
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FIGURE 6. Parasite-specific antibody levels in mice exposed to 0, 10, 100, and 1000 
p.p.m. lead acetate concentrations measured from pooled serum samples in a) 
Replicate I, b) Replicate n , and c) Replicate 1H. Data presented represent absorbances 
of serum samples diluted 1:25 and read at 490 nm. For each lead acetate 
concentration n=6 for all replicates. NMS-normal mouse serum (control) (n=2). 
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DISCUSSION 
The results of the present research confirm previous studies which have 
suggested that lead acetate possesses immunosuppressive qualities which may increase 
host susceptibility to infectious disease. However, this research project is the first that 
has evaluated the effect of exposure to lead acetate during experimental Chagas' 
disease. 
The results of the present study suggest exposure to high lead acetate 
concentrations does increase the susceptibility of C57B1/6 mice challenged with the 
Brazil strain of Trypanosoma cruzi. The greatest impact of high lead acetate exposure 
was on numbers of circulating blood-form trypomastigotes (BFTs). C57B1/6 mice 
infected with the Brazil strain of T. cruzi normally exhibit only moderate parasitemias 
and a limited degree of histopathology (Rowland et al., 1992; Sun and Tarleton, 1993). 
However, in the present study mice exposed to 100 and 1000 p.p.m. lead acetate 
experienced extremely high numbers of circulating BFTs, which is generally regarded 
as a direct indication of extensive tissue parasitism (Lima et al., 1995) and disease 
severity. Rowland et cd. (1992) reported that pathopermissive mouse strains (strains 
exhibiting a high degree of histopathology) have a much higher parasite load than 
pathoresistant strains. The high parasite loads observed in lead-treated mice in the 
present study suggest that lead-acetate may suppress the immune response to T\ cruzi. 
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Tarleton (1990) demonstrated C57B1/6 mice immunosuppressed (depleted of CD8+ T 
cells) prior to infection with T\ cruzi had higher parasitemias and increased disease 
severity as compared to nonsuppressed control mice. Furthermore, immunosuppressed 
individuals usually experience increased parasitemias, localized tissue parasites, 
increased mortality, and increased severity of symptoms of Chagas' disease (Markell et 
al, 1986; Calabrese et al, 1991). 
Highest observed numbers of circulating BFTs were detected in mice receiving 
100 and 1000 p.p.m. lead acetate concentrations in all three replicate experiments. 
Mean peak parasitemias calculated from mice receiving a lead acetate concentration of 
1000 p.p.m. (3.62 x 107 parasites/ml of blood) were sixfold higher than in 0 p.p.m. 
lead acetate-treated mice (6.49 x 106 parasites/ml of blood) (Figure 4). Also, mean 
peak parasitemias calculated from mice receiving 1000 p.p.m. lead acetate showed no 
overlap of SE bars when compared to other treatment groups (Figure 4). No statistical 
analysis was conducted on mean peak parasitemia data because different isolates were 
used in replicates I I and in, and parasitemia counts were not conducted on the same 
days post infection. However, these results strongly suggest there is a dose dependent 
effect of lead acetate resulting in increasing numbers of circulating BFTs in treated 
mice. 
Mice receiving 1000 p.p.m. lead acetate concentrations in replicate experiment 
I showed a peak of 7.1 x 107 parasites/ml of blood on day 39 post infection which was 
374 times greater than observed circulating BFTs in mice receiving 0 p.p.m. lead 
acetate (1.9 x 105 parasites/ml of blood) (Figure 5). In replicate experiment II, mice 
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receiving 100 p.p.m. lead acetate had two times more parasites/ml of blood on day 28 
post infection (9.0 x 106) than that observed in mice receiving 0 p.p.m. (3.8 x 10® 
parasites/ml of blood) (Figure 5). In replicate experiment IH, on day 14 post infection, 
mice exposed to 1000 p.p.m. lead acetate had three times more circulating BFTs than 
that observed in 0 p.p.m. lead-treated mice; however, on day 21 post infection, a peak 
of 2.7 x 106 parasites/ml of blood in mice treated with 1000 p.p.m. lead acetate 
concentrations was two times lower than that observed in mice receiving 0 p.p.m. lead 
acetate (5.5 x 106 parasites/ml of blood) (Figure 5). All of the above results were 
significantly different. 
A previous study by Grogl and Kuhn (1985) compared the course of T\ cruzi 
infection in relatively resistant C57B1/6 mice to that in C3H(He) mice, which are 
highly susceptible to infection. Both strains of mice were inoculated with 1 x 103 BFT 
of X. cruzi. It was reported that C3H(He) mice developed higher parasitemias than 
C57B1/6 mice and that parasite numbers increased faster in C3H(He) mice. C3H(He) 
mice died with high parasitemias (1.6 x 106 parasites/ml of blood) by day 24 or 25 
post infection, whereas C57B1/6 mice survived from 46-180 days post infection. 
C57B1/6 mice had peak parasitemias ranging from 5.0 x 105 to 9.0 x 105 parasites/ml 
of blood. In the present study, mice in the control group (0 p.p.m. lead acetate) had a 
mean peak parasitemia of 6.49 x 106 parasites/ml of blood. Observed numbers of 
circulating BFTs in the present study may have been higher than those described by 
Grogl and Kuhn (1985) because a tenfold greater parasite density was used for 
inoculation. 
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The high parasitemias observed in the present study suggest that lead-treated 
C57B1/6 mice are more susceptible to T. cruzi infection. However, despite the 
pronounced effect of high lead acetate concentrations on parasitemias, no increase in 
mortality was observed. The question of why the animals survived up to 275 days 
post infection with chronic exposure to high concentrations of lead acetate and high 
parasitemias still remains unanswered. The effects of lead exposure on parasites are 
unknown but lead may play an important role in altering the pathogenicity of the 
parasite. 
Immediately following the peak parasitemias in all three replicate experiments, 
there was a sharp decrease observed in parasite counts. Antibody-dependent 
complement-mediated lysis of trypomastigotes may be responsible for this rapid 
decline. Despite severe immunosuppression observed during the acute stage of 
Chagas' disease, it is well known that the parasite-specific antibodies produced during 
the course of infection have a protective effect and demonstrate lytic activity against 
the parasite (Leguizamon et al, 1991). 
To examine the effects of lead exposure on the humoral immune response to T 
cruzi. parasite-specific antibodies were measured during the course of infection. In 
contrast to previous studies (Koller and Kovacic, 1974; Blakley et al, 1980) which 
suggested that lead salts suppress antibody production, in this study all three replicate 
experiments showed no obvious pattern between high lead acetate exposure and 
lowered parasite-specific antibody production (Figure 6). 
The results from replicate experiment I suggest highest levels of anti-T cruzi 
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antibodies are being produced in mice receiving 100 and 1000 p.p.m. lead acetate just 
prior to peak parasitemias (Figures 6 and 5, respectively). In replicates II and III, 
highest levels of anti-T. cruzi antibodies in mice receiving 100 and 1000 p.p.m. lead 
acetate were observed between 20 to 27 days after the peak of circulating BFTs 
(Figure 6 and 5, respectively). Although, extremely high numbers of parasites were 
observed in the present study there was no significant correlation between parasitemias 
and antibody production. This result is in contrast to a previous study by Bennett 
(1995) which demonstrated that parasitemias had a significantly positive correlation 
with levels of anti-T cruzi antibodies in C3HeB/FeJ mice. 
The results from the present study suggest lead acetate exposure time (21 days) 
prior to T\ cruzi infection may not be long enough to cause decreased antibody 
production in this less susceptible mouse strain subsequent to infection. In previous 
studies in which decreased B-cell and antibody production was seen, experimental 
animals were exposed to lead salts for 21 (Blakley et al., 1980), 49 (Faith et al., 1979), 
56 (Koller and Kovacic, 1974), or 70 days (Koller, 1973; Koller and Brauner, 1977) 
prior to antigen exposure. In the present study, anti-T cruzi antibody levels were not 
measured late in infection (after 51 days post infection) and after chronic lead acetate 
exposure. It is possible that a decrease in parasite-specific antibody production might 
have been observed in later stages of the infection. 
In a previous study by Grogl and Kuhn (1985), parasite-specific antibody 
production was measured in C3H(He) mice and C57B1/6 mice during T\ cruzi 
infection. This study showed C57B1/6 mice produced two times more anti-T\ cruzi 
antibodies than C3H(He) mice. Immunoglobulin IgG, which is the primary antibody 
produced during the course of T. cruzi infection, peaked on days 20 and 48 for 
C3H(He) and C57B1/6 mice, respectively. Immunoglobulin IgM, peaked on day 20 
and days 25 and 40 for C3H(He) and C57B1/6 mice, respectively. The authors 
concluded that the high titer of anti-T. cruzi antibody in C57B1/6 mice was correlated 
with their increased resistance to T\ cruzi infection (Grogl and Kuhn, 1985). Parasite-
specific antibody production was highest on days 25, 40, and 48 post infection in 
C57B1/6 mice (Grogl and Kuhn, 1985); therefore, supporting the results from the 
present study which show an increase in antibody production on days 46 and 51 post 
infection in replicates II and III, respectively. 
Daily water and food consumption from each treatment group was measured 
periodically throughout the study. After conducting a regression analysis on the data, 
all slopes were shown to be negative, demonstrating a significant decrease in both 
water and food consumption over time. Replicate by treatment combinations show 
most lead-treatment groups had comparable decreases in water and food consumption, 
therefore, suggesting mice per cage received similar amounts of water and food and 
appropriate lead acetate concentrations. The observed decrease in water and food 
consumption for all lead-treated groups of mice was likely due to the progressive 
decrease in activity which was observed in mice infected with T\ cruzi. When data 
from all treatments were pooled, 100 p.p.m. lead-treated mice drank significantly more 
water than either Groups 2 (10 p.p.m.) or 4 (1000 p.p.m.) in replicate experiment I. 
No significance in among lead-treated groups was observed in replicates II and IE. 
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Results from Blakley and Archer (1981) and Blakley et al. (1980) also demonstrated 
that water consumption in lead-treated mice measured over 3 weeks was not negatively 
impacted by lead exposure. 
Individual mouse weights were measured during the course of the study. In 
replicate I, 100 p.p.m. lead acetate-treated mice weighed significantly more than mice 
treated with 1000 p.p.m. lead acetate concentrations (Figure 1); however, no statistical 
differences were observed among lead-treated groups in replicates II or HI. Mice in 
replicate I receiving 100 p.p.m. may have weighed more because they drank 
significantly more water than mice receiving 1000 p.p.m. (Figure 2). A noticeable 
drop in the weight of mice receiving 1000 p.p.m. occurred between days 50 and 181 in 
replicate H. Such a large decline in weight could be due to a temporary water loss in 
the mice. However, the long interval between weight measurements makes it difficult 
to interpret this result. In all three replicate experiments mice reached a plateau in 
weight between days 50 and 60, suggesting individual growth rates were similar 
among groups. These results are supported by the studies of Blakley et al. (1980) and 
Blakley and Archer (1981) who showed there was no significant effect of lead 
treatment on weight gain of Swiss cross mice or BDF, mice, respectively. Similarly 
Sin and Woo (1992) reported that mean body weights of lead-treated Swiss albino 
mice were not significantly different when compared to the control group. However, 
one study by Koller (1973) showed New Zealand White rabbits exposed to 2500 
p.p.m. lead acetate concentrations weighed significantly less than non-lead-treated 
control rabbits. 
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Mice were observed for signs of Chagas' disease and lead toxicity. Late in 
infection 100 and 1000 p.p.m. lead acetate-treated mice became lethargic and 
characteristic "humped backs" were observed along with weakened hind legs. 
Toxicological signs observed were predominantly in mice treated with 100 and 1000 
p.p.m. lead acetate which included hair loss and what was thought to be neurological 
damage. The only observed mortality in the study was one mouse (in replicate I) 
receiving 1000 p.p.m. lead acetate which died on day 63 post infection with low body 
weight and obvious signs of Chagas' disease. 
The results from the present study support previous studies which have 
suggested that exposure to lead increases susceptibility to infectious agents (Hemphill 
et al., 1971; Roller, 1973; Koller and Kovacic, 1974; Lawrence, 1981; and Sin and 
Woo, 1992). C57B1/6 mice exposed to 100 and 1000 p.p.m. lead acetate 
concentrations had mean peak parasitemias which were significantly higher when 
compared to control mice and respectively, nineteen times and fifty-two times higher 
than peak parasitemias of non-1 ead-treated, T\ cruzi infected, C57B1/6 mice observed 
by Grogl and Kuhn (1985). Tissue levels of parasites and tissue destruction also 
would be expected to be greater in mice with higher parasitemias, however, 
histological studies will be necessary to confirm this prediction. 
It will be important for future studies to determine the effects of lead acetate 
exposure on CD4+ T helper and CD8+ T cytotoxic activity during T\ cruzi infection. 
Faith et al. (1979) demonstrated exposure to lead salts had a negative impact on cell-
mediated immunity by decreasing T-cell proliferation. Lead has also been shown to 
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affect CD4+ T-cell function (McCabe and Lawrence, 1990) and inhibit Th 1 
subpopulation function (Kowolenko et al., 1992). 
As a follow-up to the present study, the laboratory will evaluate the effects of 
lead acetate exposure in C3H(He) mice, which are highly susceptible to challenge with 
1\ cruzi. This project will evaluate the effect of lead exposure on parasitemia and 
mortality, evaluate the effects of lead exposure and T cruzi on cardiac and skeletal 
muscle, liver, and kidney tissues, and evaluate water and weight changes of the lead-
treated mice when infected with T cruzi. 
Since 1970 many natural and synthetic substances have been shown to alter the 
immune response and cause increased susceptibility to disease. With the rapid 
progression of technology, it is important to be cognizant of the continuous work of 
pharmaceutical companies (producing "newer and better" drugs) and chemical 
companies (producing pesticides, synthetic fibers, etc.) as we approach the 21st century. 
Due to such environmental health concerns, the past 20 years have been important in 
evaluating environmental contaminants and toxicants which may have a negative 
impact on the immune response therefore increasing susceptibility to infectious agents. 
However, little research has been done to evaluate the effects of environmental 
toxicants during parasitic infection. The topic of parasitic disease receives little 
attention in the U. S., however, an estimated one billion of the world's population is 
currently suffering from parasitic infection (Goodman, 1994). Furthermore, infectious 
and parasitic diseases account for more than half the total burden of morbidity and 
mortality in Sub-Saharan Africa, India, and much of Asia (Evans and Jamison, 1994). 
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Therefore, in light of the results of the present study, future studies should be designed 
to further evaluate the effect of environmental toxicants, such as lead, during parasitic 
infection. 
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